merck oral glp-1 Semaglutide and the Future of Obesity Treatment, With Timothy Garvey, MD Merck's long-awaited obesity move is
Description
In this first article of our two-part series, well explore the scientific evidence behind facial changes during GLP-1-assisted weight loss
Decreased appetite: Helps support weight loss but may lead to fatigue if nutrient intake is insufficient
Middleton, S
, Meier, D
METHODS Study design and data source We conducted a retrospective observational analysis of real-world prescribing and weight data for patients treated with GLP-1 RA for weight management
